"Cancer" is as wide a designation as "star".. the different types and their various characteristics, even in the same cell / tissue type, are numerous. A malignancy can exhibit CCR5 overexpression and still have a co-factor (or several) that mean it (ultimately) won't necessarily respond to Leronlimab.

But then there's the ones that do. And it looks like they really, really do.